Related Experiment Videos
Extremity and non-extremity high-grade osteosarcoma -- the Norwegian Radium Hospital experience during the modern
G Saeter1, O S Bruland, G Follerås
1Department of Medical Oncology and Radiotherapy, The Norwegian Radium Hospital, Oslo.
Acta Oncologica (Stockholm, Sweden)
|January 1, 1996
Summary
High-grade osteosarcoma outside the extremities affects older patients and has poorer outcomes. New treatments are crucial for these non-extremity tumors, especially in older adults.
Area of Science:
- Orthopedics
- Oncology
- Medical Research
Background:
- High-grade osteosarcoma is a rare bone cancer.
- Tumors typically occur in the extremities.
- Non-extremity osteosarcoma represents a distinct clinical challenge.
Purpose of the Study:
- To compare outcomes of high-grade osteosarcoma based on tumor location (extremity vs. non-extremity).
- To identify factors influencing treatment adequacy and survival.
- To highlight the need for improved treatment strategies for non-extremity osteosarcoma.
Main Methods:
- Retrospective analysis of 103 patients with high-grade osteosarcoma.
- Comparison of patient demographics, treatment received, and survival rates.
- Stratification by tumor location and participation in clinical trials.
Main Results:
- 27% of osteosarcomas were non-extremity, with older patients (median 38 vs. 17 years).
- Adequate treatment (chemotherapy + surgery) was received by >90% of extremity vs. 25% of non-extremity cases.
- Non-extremity tumors showed significantly worse local control and overall survival.
Conclusions:
- Non-extremity high-grade osteosarcoma patients are older, undertreated, and have poorer outcomes.
- Current clinical trial data for 'classical' extremity osteosarcoma may not represent all patients.
- Novel therapeutic approaches are urgently needed for non-extremity osteosarcoma, particularly in elderly patients.